| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.095 | 0.05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.098 | 0.05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.041 | 0.4 |